HAEMOPHILIA A WITH OR WITHOUT INHIBITORS
Clinical trials for HAEMOPHILIA A WITH OR WITHOUT INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA A WITH OR WITHOUT INHIBITORS trials appear
Sign up with your email to follow new studies for HAEMOPHILIA A WITH OR WITHOUT INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot could help kids with hemophilia a avoid bleeds
Disease control CompletedThis study tested a new medicine called Mim8 in 70 children aged 1-11 with hemophilia A, some of whom had inhibitors that make standard treatments less effective. Mim8 is given as a shot under the skin to help prevent bleeding episodes. The study lasted about 54-98 weeks and trac…
Matched conditions: HAEMOPHILIA A WITH OR WITHOUT INHIBITORS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New weekly shot could stop bleeding for hemophilia patients
Disease control CompletedThis study tested a new medicine called Mim8 for people with hemophilia A, a condition where blood doesn't clot properly. Mim8 is a shot given under the skin that helps replace the missing clotting factor. The trial included 275 people, some healthy and some with hemophilia, to s…
Matched conditions: HAEMOPHILIA A WITH OR WITHOUT INHIBITORS
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 13, 2026 15:59 UTC